Synovitis Recruiting Phase 1 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0016437 (Synovitis)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02060305Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic SynovitisTreatment